Huh Hoyoung 13D/13G Filings for Akari Therapeutics, Plc (AKTX)

Huh Hoyoung 13D and 13G filings for Akari Therapeutics, Plc:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2025-02-14
5:00 pm
Purchase
2024-11-14 13G Akari Therapeutics, Plc
AKTX
Huh Hoyoung 8,294,508,000
15.500%
8,294,508,000increase
(New Position)
Filing